S&P DJI Announces June 2020 Quarterly Rebalance
Filed with ASX · · 10 pages · English
Medical Developments International Limited on 6ix
Earlier from Medical Developments International
- Penthrox approved in Hungary
- Penthrox approved - Netherlands and Bosnia and Herzegovina
- Penthrox is approved in Thailand
- COVID-19 Impact on MVP
- MVP announces leadership change
Later from Medical Developments International
- Medical Developments to take control of EU markets
- Appointment of Non-Executive Director - Gordon Naylor
- Appointment of CEO - Brent MacGregor
- Chairmans and CEOs Address to Shareholders
- MVP and MundiPharma cease Australian licensing agreement
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International